Two defendants were sentenced in the first instance of Ciwujia injection death

March 15 is the international consumer rights day The two defendants were sentenced in the first instance in the Grand Court of the people's Court of Kaiyuan city, Yunnan Province, Monday The court held that the defendant, Zhang Guohong, as a drug distributor of Heilongjiang Wandashan Pharmaceutical Co., Ltd., violated the drug management law and the quality management standards of drug production and operation, and sold Ciwujia injection, which was damaged in some bottles and outer packages, soaked by rainwater and contaminated with biological toxins, during the round-trip transportation, resulting in three deaths and many injuries As the director of the quality assurance department of the company, Wang Ruping, the defendant, knew that the external package of Ciwujia injection had been damaged during the transportation and soaked in rainwater According to the provisions of the drug management law, sales should be prohibited, and Zhang Guohong was still agreed to replace the external package for sales Both of the defendants have a laissez faire attitude towards the occurrence of the above harmful results The acts of the defendants Zhang Guohong and Wang Ruping constitute the crime of selling fake drugs According to the court, unlike general commodities and goods, drugs are directly related to the life and health and safety of others The production, transportation, storage and use of drugs must be carried out in strict accordance with relevant laws and regulations and operating procedures In the first instance of the court, Zhang Guohong and Wang Ruping were sentenced in public according to law Zhang Guohong was sentenced to seven years' imprisonment for the crime of selling fake drugs and a fine of 9000 yuan Wang Ruping was sentenced to three years' imprisonment for the crime of selling fake drugs, a five-year reprieve and a fine of 9000 yuan After the application of the parties and the mediation of the court, Heilongjiang Wandashan Pharmaceutical Co., Ltd affiliated to the defendants Zhang Guohong and Wang Ruping, Guangdong Zhanjiang Zhongxing Pharmaceutical Co., Ltd and the Fourth People's Hospital of Honghe Prefecture voluntarily reached a compensation agreement with the victims and their relatives in December 2009 The total amount of compensation is RMB 3 924367.06 yuan, and the defendant has actively performed the obligations determined in the agreement On October 6, 2008, Yunnan food and Drug Administration reported that six patients in the Fourth People's Hospital of Honghe Prefecture in Yunnan Province had serious adverse reactions after using "Ciwujia" injection produced by Heilongjiang Wandashan pharmaceutical factory, among which three died The next day, the Ministry of health of China and the State Food and Drug Administration issued an emergency notice to suspend the sale and use of the injection In October of the same year, the relevant national departments jointly reported that some samples of some batches of Ciwujia injection produced by Wandashan pharmaceutical factory in Heilongjiang Province were contaminated by bacteria Subsequently, Chinese provinces began to strictly inspect the injection of Acanthopanax senticosus.